Holen Sie sich die Stockscreener-App
86.64
1.74%
-1.53
Handel nachbörslich:
86.64
Vaxcyte Inc Aktie (PCVX) Neueste Nachrichten
CARGO Therapeutics, Inc. Enters into Sublease Agreement with Vaxcyte, Inc -July 08, 2024 at 04:18 pm EDT - Marketscreener.com
Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market - MSN
Why Vaxcyte, Inc. (PCVX) Is One of the Best Russell 2000 Stocks to Invest in According to Analysts? - Insider Monkey
Vaxcyte (NASDAQ:PCVX) Trading Up 7.8%Should You Buy? - MarketBeat
Teri Loxam Sells 6,250 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock - MarketBeat
Alexandria Announces Long-Term Lease at San Carlos Mega Campus - MSN
Learn to Evaluate (PCVX) using the Charts - Stock Traders Daily
Vaxcyte (NASDAQ:PCVX) Stock Price Up 7.8%Here's What Happened - MarketBeat
Vaxcyte Aims To Outshine Pfizer With Bold VAX-31 Strategy (NASDAQ:PCVX) - Seeking Alpha
Leerink Partnrs Forecasts Vaxcyte FY2029 Earnings - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Harbor Capital Advisors Inc. - MarketBeat
Diversified Trust Co Acquires New Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte's SVP Mikhail Eydelman sells $427,922 in stock - Investing.com India
Vaxcyte's SVP Mikhail Eydelman sells $427,922 in stock By Investing.com - Investing.com Canada
Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm - The Malaysian Reserve
Long Term Trading Analysis for (PCVX) - Stock Traders Daily
Brokerages Set Vaxcyte, Inc. (NASDAQ:PCVX) Target Price at $145.71 - MarketBeat
Vaxcyte COO Jim Wassil sells shares valued at $669,266 By Investing.com - Investing.com Australia
Jim Wassil Sells 8,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock - MarketBeat
Vaxcyte COO Jim Wassil sells shares valued at $669,266 - Investing.com
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Principal Financial Group Inc. - MarketBeat
Trump and Interest Rates: The 2 Key Reasons This Vanguard ETF Could Thrive in 2025 - The Motley Fool
Vaxcyte (NASDAQ:PCVX) Trading Down 5.8%Here's What Happened - MarketBeat
When (PCVX) Moves Investors should Listen - Stock Traders Daily
Is Vaxcyte, Inc. (PCVX) the Best Performing Biotech Stock in 2024? - MSN
10 Best Performing Biotech Stocks in 2024 - Insider Monkey
Vaxcyte stock supported by Goldman Sachs for addressing next-gen vaccine challenges - Investing.com Canada
Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset - MSN
Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset (PCVX:NASDAQ) - Seeking Alpha
Vaxcyte (NASDAQ:PCVX) Coverage Initiated at The Goldman Sachs Group - MarketBeat
Vaxcyte's president and CFO sells $710,248 in stock transactions - Investing.com India
Vaxcyte's president and CFO sells $710,248 in stock transactions By Investing.com - Investing.com Canada
Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CFO Sells 8,000 Shares of Stock - MarketBeat
Vaxcyte’s president and CFO sells $710,248 in stock transactions By Investing.com - Investing.com Nigeria
(PCVX) Investment Report - Stock Traders Daily
Lord Abbett & CO. LLC Raises Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Franklin Resources Inc. Raises Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Geode Capital Management LLC Buys 259,010 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Receives $147.50 Average Price Target from Analysts - MarketBeat
Applied Industrial Technologies (AIT-N) QuotePress Release - The Globe and Mail
Merck & Company (MRK-N) QuotePress Release - The Globe and Mail
Why Wall Street Rates These 2 Russell 2000 Stocks a “Strong Buy” - MSN
Pfizer Inc (PFE-N) QuotePress Release - The Globe and Mail
1.44%
7.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):